FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal Trade Commission (FTC) uncovered in its second interim staff report rele | The FTC released its second interim staff report Tuesday during Chair Lina Khan's final open commission meeting,
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...
The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...
The Massachusetts Democrat is working with a Missouri Republican, and House members from each party, to press the FTC to ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
Known as the middlemen of the pharma industry, PBMs play an intermediary role between health insurers, pharmacies and ...
Newer entrants to the pharmacy benefit management market will continue to face stiff competition in 2025 as they seek more ...
The Arkansas Pharmacists Association is calling for public and legislative support for stronger regulation of Pharmacy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback